SG11201408731WA - USE OF 2-METHYLENE-19-NOR-(20S)-1α,25-DIHYDROXYVITAMIN D<sb>3</sb> TO TREAT SECONDARY HYPERPARATHYROIDISM - Google Patents

USE OF 2-METHYLENE-19-NOR-(20S)-1α,25-DIHYDROXYVITAMIN D<sb>3</sb> TO TREAT SECONDARY HYPERPARATHYROIDISM

Info

Publication number: SG11201408731WA
Authority: SG; Singapore
Prior art keywords: dihydroxyvitamin; methylene; secondary hyperparathyroidism; treat secondary; treat
Prior art date: 2012-06-29

Application number

SG11201408731WA

Other languages

English (en)

Inventor

Hector F Deluca

Lori A Plum

Julia B Zella

Margaret Clagett-Dame

Original Assignee

Wisconsin Alumni Res Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-06-29

Filing date

2013-03-14

Publication date

2015-01-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47997980&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201408731W(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-03-14 Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found

2015-01-29 Publication of SG11201408731WA publication Critical patent/SG11201408731WA/en

Links

208000005770 Secondary Hyperparathyroidism Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

SG11201408731WA 2012-06-29 2013-03-14 USE OF 2-METHYLENE-19-NOR-(20S)-1α,25-DIHYDROXYVITAMIN D<sb>3</sb> TO TREAT SECONDARY HYPERPARATHYROIDISM SG11201408731WA (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201261666264P	2012-06-29	2012-06-29
PCT/US2013/031574 WO2014003849A1 (en)	2012-06-29	2013-03-14	USE OF 2-METHYLENE-19-NOR-(20S)-1α,25-DIHYDROXYVITAMIN D3 TO TREAT SECONDARY HYPERPARATHYROIDISM

Publications (1)

Publication Number	Publication Date
SG11201408731WA true SG11201408731WA (en)	2015-01-29

Family

ID=47997980

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG11201408731WA SG11201408731WA (en)	2012-06-29	2013-03-14	USE OF 2-METHYLENE-19-NOR-(20S)-1α,25-DIHYDROXYVITAMIN D<sb>3</sb> TO TREAT SECONDARY HYPERPARATHYROIDISM

Country Status (19)

Country	Link
US (4)	US9205096B2 (ru)
EP (1)	EP2866811A1 (ru)
JP (1)	JP2015522015A (ru)
KR (1)	KR20150030673A (ru)
CN (1)	CN104394871A (ru)
AU (1)	AU2013281217B2 (ru)
BR (1)	BR112014032847A2 (ru)
CA (1)	CA2877680C (ru)
CL (1)	CL2014003565A1 (ru)
CO (1)	CO7240358A2 (ru)
HK (1)	HK1206600A1 (ru)
IL (1)	IL236184A0 (ru)
MX (1)	MX2015000076A (ru)
MY (1)	MY172886A (ru)
NZ (1)	NZ703347A (ru)
RU (1)	RU2666995C2 (ru)
SG (1)	SG11201408731WA (ru)
WO (1)	WO2014003849A1 (ru)
ZA (1)	ZA201500119B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2015522015A (ja) *	2012-06-29	2015-08-03	ウイスコンシンアラムニリサーチファンデーション	続発性副甲状腺機能亢進症を治療するための２−メチレン−１９−ノル−（２０Ｓ）−１α，２５−ジヒドロキシビタミンＤ３の使用
DK3049979T3 (da) *	2013-09-27	2020-02-17	Codexis Inc	Struktur-baseret prædiktiv konstruktion
RU2016116253A (ru)	2013-09-27	2017-11-01	Кодексис, Инк.	Автоматизированный скрининг вариантов фермента
CN103533522A (zh) *	2013-10-25	2014-01-22	从兴技术有限公司	短信稽核的方法及***
EP3193925A2 (en) *	2014-08-07	2017-07-26	OPKO Ireland Global Holdings, Ltd.	Adjunctive therapy with 25-hydroxyvitamin d
US9539264B2 (en) *	2014-12-30	2017-01-10	Wisconsin Alumni Research Foundation	Use of 2-methylene-19-nor-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism in patients previously treated with calcimimetics
US10369161B2 (en)	2014-12-30	2019-08-06	Wisconsin Alumni Research Foundation	Use of 2-methylene-19-NOR-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat primary hyperparathyroidism
WO2018044468A1 (en)	2016-08-30	2018-03-08	Wisconsin Alumni Research Foundation	COMBINATION OF LOW DOSE 2-METHYLENE-19-NOR-(20S)-1α, 25-DIHYDROXYVITAMIN D3 AND CALCIMIMETICS TO TREAT SECONDARY HYPERPARATHYROIDISM

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040043971A1 (en)	1995-04-03	2004-03-04	Bone Care International, Inc.	Method of treating and preventing hyperparathyroidism with active vitamin D analogs
US5843928A (en)	1997-03-17	1998-12-01	Wisconsin Alumni Research Foundation	2-alkylidene-19-nor-vitamin D compounds
US6306844B1 (en)	1997-03-17	2001-10-23	Wisconsin Alumni Research Foundation	Use of 2α-methyl-19-nor-20(S)-1α, 25-dihydroxyvitamin D3 to increase bone strength
US6136799A (en)	1998-04-08	2000-10-24	Abbott Laboratories	Cosolvent formulations
US6673782B2 (en)	1999-04-29	2004-01-06	Wisconsin Alumni Research Foundation	Treatment of systemic lupus erythematosis
EP1267886B1 (en)	2000-03-27	2006-03-08	Wisconsin Alumni Research Foundation	Vitamin d compounds for the treatment of chronic allograft nephropathy in kidney transplant patients
NZ537036A (en)	2000-07-14	2006-07-28	Wisconsin Alumni Res Found	Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength
US20080249068A1 (en)	2002-09-05	2008-10-09	Deluca Hector F	Method of Extending the Dose Range of Vitamin D Compounds
US20050124591A1 (en)	2003-07-29	2005-06-09	Jin Tian	Use of vitamin Ds to treat kidney disease
US20060171983A1 (en)	2003-07-30	2006-08-03	Jin Tian	Use of Vitamin D receptor activators or Vitamin D analogs to treat cardiovascular disease
NZ545632A (en) *	2003-09-19	2009-09-25	Wisconsin Alumni Res Found	2-Alkylidene-19-nor-vitamin D derivatives for the treatment of frailty, muscle damage or sarcopenia
US7704980B2 (en)	2003-10-08	2010-04-27	Wisconsin Alumni Research Foundation	Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin D compounds
US7214671B2 (en)	2004-02-19	2007-05-08	Wisconsin Alumni Research Foundation	Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 for the prophylaxis of bone diseases
MX2007009726A (es)	2005-02-11	2007-09-26	Wisconsin Alumni Res Found	2-metilen-19-nor-(20s-24s)-1a, 25-dihidroxivitamina-d2.
US7528122B2 (en) *	2006-02-02	2009-05-05	Wisconsin Alumni Research Foundation	Vitamin D analog—NEL, methods and uses thereof
WO2011017165A1 (en) *	2009-08-03	2011-02-10	Wisconsin Alumni Research Foundation	Method of preventing renal disease and treating symptoms thereof
WO2011119610A2 (en)	2010-03-23	2011-09-29	Wisconsin Alumni Research Foundation	(20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1α,25- DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22- DIMETHYL-1α,25-HYDROXYVITAMIN D3
JP2015522015A (ja) *	2012-06-29	2015-08-03	ウイスコンシンアラムニリサーチファンデーション	続発性副甲状腺機能亢進症を治療するための２−メチレン−１９−ノル−（２０Ｓ）−１α，２５−ジヒドロキシビタミンＤ３の使用

2013
- 2013-03-14 JP JP2015520165A patent/JP2015522015A/ja active Pending
- 2013-03-14 CN CN201380034681.7A patent/CN104394871A/zh active Pending
- 2013-03-14 RU RU2015102831A patent/RU2666995C2/ru not_active IP Right Cessation
- 2013-03-14 NZ NZ703347A patent/NZ703347A/en not_active IP Right Cessation
- 2013-03-14 BR BR112014032847A patent/BR112014032847A2/pt not_active Application Discontinuation
- 2013-03-14 WO PCT/US2013/031574 patent/WO2014003849A1/en active Application Filing
- 2013-03-14 AU AU2013281217A patent/AU2013281217B2/en not_active Ceased
- 2013-03-14 CA CA2877680A patent/CA2877680C/en not_active Expired - Fee Related
- 2013-03-14 KR KR20147036464A patent/KR20150030673A/ko not_active Application Discontinuation
- 2013-03-14 MX MX2015000076A patent/MX2015000076A/es unknown
- 2013-03-14 SG SG11201408731WA patent/SG11201408731WA/en unknown
- 2013-03-14 US US13/828,090 patent/US9205096B2/en not_active Expired - Fee Related
- 2013-03-14 MY MYPI2014003594A patent/MY172886A/en unknown
- 2013-03-14 EP EP13712121.6A patent/EP2866811A1/en not_active Withdrawn
2014
- 2014-03-07 US US14/201,091 patent/US9034853B2/en not_active Expired - Fee Related
- 2014-12-11 IL IL236184A patent/IL236184A0/en unknown
- 2014-12-29 CL CL2014003565A patent/CL2014003565A1/es unknown
2015
- 2015-01-08 ZA ZA2015/00119A patent/ZA201500119B/en unknown
- 2015-01-23 CO CO15013584A patent/CO7240358A2/es unknown
- 2015-07-24 HK HK15107093.4A patent/HK1206600A1/xx unknown
- 2015-11-20 US US14/947,142 patent/US9717744B2/en not_active Expired - Fee Related
2017
- 2017-05-24 US US15/604,069 patent/US10046000B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20140005152A1 (en)	2014-01-02
US10046000B2 (en)	2018-08-14
BR112014032847A2 (pt)	2017-06-27
IL236184A0 (en)	2015-01-29
AU2013281217A1 (en)	2015-01-22
JP2015522015A (ja)	2015-08-03
RU2015102831A (ru)	2016-08-20
CA2877680C (en)	2017-08-29
EP2866811A1 (en)	2015-05-06
HK1206600A1 (en)	2016-01-15
US20170252360A1 (en)	2017-09-07
MY172886A (en)	2019-12-13
KR20150030673A (ko)	2015-03-20
US9034853B2 (en)	2015-05-19
US9205096B2 (en)	2015-12-08
MX2015000076A (es)	2015-04-10
CL2014003565A1 (es)	2015-08-28
WO2014003849A1 (en)	2014-01-03
US20160136184A1 (en)	2016-05-19
CA2877680A1 (en)	2014-01-03
NZ703347A (en)	2016-05-27
CN104394871A (zh)	2015-03-04
ZA201500119B (en)	2017-11-29
RU2666995C2 (ru)	2018-09-13
AU2013281217B2 (en)	2017-03-02
US9717744B2 (en)	2017-08-01
US20140187522A1 (en)	2014-07-03
CO7240358A2 (es)	2015-04-17

Publication	Publication Date	Title
SG11201408731WA (en)	2015-01-29	USE OF 2-METHYLENE-19-NOR-(20S)-1α,25-DIHYDROXYVITAMIN D<sb>3</sb> TO TREAT SECONDARY HYPERPARATHYROIDISM
CO7061082A2 (es)	2014-09-19	Compuestos para tratar la artrofia muscular espinal
SI3336097T1 (sl)	2021-07-30	Priprava nekristalinične oblike obetiholne kisline
EP2880501A4 (en)	2016-07-06	OPTIMIZING ENERGY UTILIZATION BY SIMULATIONS BASED ON A MODEL
HRP20171889T1 (hr)	2018-01-12	Formulacije kombinacije darunavira
EP2901245A4 (en)	2016-05-25	EFFICIENT LOW POWER OUTPUT SEQUENCE FOR PERIPHERAL DEVICES
ZA201504408B (en)	2017-09-27	Solution formulations of engineered anti-il-23p19 antibodies
PL2888639T3 (pl)	2018-07-31	Transformator rozdzielczy
EP2664072A4 (en)	2014-07-23	EMERGENCY BEACON
IL235802A0 (en)	2015-02-01	A new process for the preparation of 2-cyclopentyl-6-methoxy-isonicotinic acid
IL229700B (en)	2018-04-30	Dronvir formulations
IL237483A0 (en)	2015-04-30	Preparations for the treatment of psoriasis
GB201222683D0 (en)	2013-01-30	Chemical reactor
PL2484602T3 (pl)	2017-02-28	Taśmy opasujące z surowców odnawialnych
EP3240549A4 (en)	2018-08-29	Use of 2-methylene-19-nor-(20s)-1a,25-dihydroxyvitamin d3 to treat secondary hyperparathyroidism
PL2730279T3 (pl)	2015-12-31	Preparaty cynakalcetu o natychmiastowym uwalnianiu
PL2702045T3 (pl)	2018-04-30	Nowy sposób sporządzania Etrawiryny
SG11201406582XA (en)	2014-11-27	Intrauterine application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems, intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one, as well as the
GB201214053D0 (en)	2012-09-19	OO infinity radil generating plant
TH1201002015B (th)	2016-03-04	วิธีการปรับปรุงโครงสร้างของพอลิเอทธิลีน แวกซ์ โดยปฏิกิริยาโบรมิเนชัน
AP2013006750A0 (en)	2013-02-28	Pole-type distribution transformer
GB201220869D0 (en)	2013-01-02	Process for sysnthesis of C2-substitutes analogues of 1a,25-dihydroxyvitamin D3
TWM433220U (en)	2012-07-11	Self-generated power transmission mechanism for exercise equipment